Phase I, Multiple escalating dose study evaluating the safety and tolerability of capecitabine combined with CPT-11 in patients with metastatic breast cancer who had previously treated with anthracyclines and taxanes

Trial Profile

Phase I, Multiple escalating dose study evaluating the safety and tolerability of capecitabine combined with CPT-11 in patients with metastatic breast cancer who had previously treated with anthracyclines and taxanes

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Capecitabine (Primary) ; Irinotecan (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top